Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piazza

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Medical Care|December 8, 2025
An Innovative Nurse Navigator Approach to Screen For and Address Social Needs in a Veterans Health Administration Women's Health ClinicMarguerite Daus, Laurie Pfeiffer, Meaghan A Kennedy, et al.
Veterinary Pathology|September 19, 2013
Temporal and geographic clustering of polyomavirus-associated olfactory tumors in 10 free-ranging raccoons (Procyon lotor)F Giannitti, R J Higgins, P A Pesavento, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Vaccine|November 3, 2009
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasisIván D Vélez, Katherine Gilchrist, Sofía Martínez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
The Journal of Infectious Diseases|August 6, 2004
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutantsJohn P DeVincenzo, Caroline B Hall, David W Kimberlin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 3, 1999
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced diseaseM Floridia, R Bucciardini, D Ricciardulli, et al.
Journal of Psychosomatic Research|May 27, 2017
Fear and distress disorders as predictors of heart disease: A temporal perspectiveA M Roest, P de Jonge, C W W Lim, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Medical Care|December 8, 2025
An Innovative Nurse Navigator Approach to Screen For and Address Social Needs in a Veterans Health Administration Women's Health ClinicMarguerite Daus, Laurie Pfeiffer, Meaghan A Kennedy, et al.
Veterinary Pathology|September 19, 2013
Temporal and geographic clustering of polyomavirus-associated olfactory tumors in 10 free-ranging raccoons (Procyon lotor)F Giannitti, R J Higgins, P A Pesavento, et al.
NPJ Vaccines|September 14, 2018
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trialRhea N Coler, Tracey A Day, Ruth Ellis, et al.
Vaccine|November 3, 2009
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasisIván D Vélez, Katherine Gilchrist, Sofía Martínez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
The Journal of Infectious Diseases|August 6, 2004
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutantsJohn P DeVincenzo, Caroline B Hall, David W Kimberlin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 3, 1999
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced diseaseM Floridia, R Bucciardini, D Ricciardulli, et al.
Journal of Psychosomatic Research|May 27, 2017
Fear and distress disorders as predictors of heart disease: A temporal perspectiveA M Roest, P de Jonge, C W W Lim, et al.
Pageof 28